Journal
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
Volume 94, Issue 2, Pages 124-136Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09553002.2018.1407462
Keywords
GNP; ALTS1C1; cyclic RGD; radiosensitization; proton therapy
Funding
- Ministry of Science and Technology, Taiwan
- Chang Gung Memorial Hospital, LinKou, Taiwan [CMRPG3E13012, CIRPG3D0141, CIRPD1E0053]
Ask authors/readers for more resources
Purpose: One of the promising radiosensitizers is the ultrasmall gold nanoparticle (GNP) with a hydrodynamic diameter <3 nm. We studied functionalized ultrasmall GNPs (1.8 nm diameter) coated by polyethylene glycol (PEG) and conjugated with cyclic RGDfK (2.6nm hydrodynamic diameter) for targeting of alpha(v) beta(3) integrin (alpha(v)beta(3)) in the murine ALTS1C1 glioma cell line. Materials and methods: We investigated the uptake, toxicity and radiosensitivity of GNP-PEG-cRGDfKs in ALTS1C1 cells exposed to protons, kilovoltage photons and megavoltage photons. The in vitro uptake and toxicity of GNPs in the hepatocytes and Kupffer cells were assessed for murine AML12 hepatocyte and RAW 264.7 macrophage cell lines. The in vivo biodistribution of GNPs in the ALTS1C1 tumor model was tested using the inductively coupled plasma mass spectrometry. Results: Results indicated GNPs accumulated in the cytoplasm with negligible toxicity for a moderate concentration of GNPs. Observed sensitizer enhancement ratios and dose enhancement factors are 1.21-1.66 and 1.14-1.33, respectively, for all radiations. Conclusion: Ultrasmall GNP-PEG-cRGD can be considered as a radiosensitizer. For radiotherapy applications, the delivery method should be developed to increase the GNP uptake in the tumor and decrease the uptakes in undesirable organs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available